Clinical Forum Insights
Please check back later for more content.
Advertisement
Advertisement
Trending on Urology Times
1
Trial to compare 225Ac-PSMA-617 vs 177Lu-PSMA-617 for oligorecurrent prostate cancer
2
Farah Rahman, MD, on monitoring resident wellness using biofeedback
3
John Sfakianos, MD, on dual immune checkpoint inhibition in NMIBC
4
Veda Giri, MD, on patient-reported outcomes with prostate cancer genetic testing
5
